[KLK] QoQ Annualized Quarter Result on 31-Dec-2011 [#1]

Announcement Date
22-Feb-2012
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2012
Quarter
31-Dec-2011 [#1]
Profit Trend
QoQ- -13.2%
YoY- 12.1%
View:
Show?
Annualized Quarter Result
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Revenue 10,570,188 10,867,413 11,094,762 11,692,708 10,743,252 10,324,792 9,582,674 6.73%
PBT 1,560,436 1,450,221 1,549,614 1,852,820 2,066,205 1,955,941 1,792,224 -8.79%
Tax -300,347 -343,886 -372,718 -421,580 -420,674 -396,393 -363,684 -11.94%
NP 1,260,089 1,106,334 1,176,896 1,431,240 1,645,531 1,559,548 1,428,540 -8.00%
-
NP to SH 1,211,244 1,051,970 1,111,786 1,363,940 1,571,413 1,481,065 1,356,080 -7.23%
-
Tax Rate 19.25% 23.71% 24.05% 22.75% 20.36% 20.27% 20.29% -
Total Cost 9,310,099 9,761,078 9,917,866 10,261,468 9,097,721 8,765,244 8,154,134 9.21%
-
Net Worth 7,113,970 6,783,831 7,007,233 7,348,263 7,071,145 6,784,074 6,357,623 7.75%
Dividend
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Div 692,227 212,993 319,478 - 905,191 213,000 319,478 67.20%
Div Payout % 57.15% 20.25% 28.74% - 57.60% 14.38% 23.56% -
Equity
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Net Worth 7,113,970 6,783,831 7,007,233 7,348,263 7,071,145 6,784,074 6,357,623 7.75%
NOSH 1,064,965 1,064,965 1,064,929 1,064,965 1,064,931 1,065,003 1,064,928 0.00%
Ratio Analysis
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
NP Margin 11.92% 10.18% 10.61% 12.24% 15.32% 15.10% 14.91% -
ROE 17.03% 15.51% 15.87% 18.56% 22.22% 21.83% 21.33% -
Per Share
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 992.54 1,020.45 1,041.83 1,097.94 1,008.82 969.46 899.84 6.73%
EPS 113.74 98.77 104.40 128.08 147.56 139.07 127.34 -7.23%
DPS 65.00 20.00 30.00 0.00 85.00 20.00 30.00 67.20%
NAPS 6.68 6.37 6.58 6.90 6.64 6.37 5.97 7.75%
Adjusted Per Share Value based on latest NOSH - 1,064,965
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
RPS 961.81 988.86 1,009.54 1,063.95 977.56 939.48 871.96 6.73%
EPS 110.21 95.72 101.16 124.11 142.99 134.77 123.39 -7.23%
DPS 62.99 19.38 29.07 0.00 82.37 19.38 29.07 67.21%
NAPS 6.4732 6.1728 6.3761 6.6864 6.4342 6.173 5.785 7.75%
Price Multiplier on Financial Quarter End Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 31/03/11 -
Price 22.06 22.94 24.60 22.70 21.10 22.16 21.20 -
P/RPS 2.22 2.25 2.36 2.07 2.09 2.29 2.36 -3.98%
P/EPS 19.40 23.22 23.56 17.72 14.30 15.93 16.65 10.69%
EY 5.16 4.31 4.24 5.64 6.99 6.28 6.01 -9.64%
DY 2.95 0.87 1.22 0.00 4.03 0.90 1.42 62.59%
P/NAPS 3.30 3.60 3.74 3.29 3.18 3.48 3.55 -4.73%
Price Multiplier on Announcement Date
30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 CAGR
Date 21/11/12 29/08/12 24/05/12 22/02/12 23/11/11 16/08/11 25/05/11 -
Price 20.56 23.24 22.16 23.64 21.38 21.10 21.50 -
P/RPS 2.07 2.28 2.13 2.15 2.12 2.18 2.39 -9.11%
P/EPS 18.08 23.53 21.23 18.46 14.49 15.17 16.88 4.67%
EY 5.53 4.25 4.71 5.42 6.90 6.59 5.92 -4.42%
DY 3.16 0.86 1.35 0.00 3.98 0.95 1.40 71.81%
P/NAPS 3.08 3.65 3.37 3.43 3.22 3.31 3.60 -9.85%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment